Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4B | 1.7B | 1.5B | 1.5B |
Cost of revenue | 862M | 1.0B | 918M | 895M |
Gross profit | 586M | 653M | 619M | 588M |
Operating expense | ||||
Research & development | 66M | 61M | 66M | 69M |
Selling general and admin | 435M | 438M | 422M | 429M |
Other operating expenses | 1M | — | 1M | 1M |
Operating income | 85M | 179M | 137M | 98M |
Non operating interest income | ||||
Income | 8M | 9M | 7M | 11M |
Expense | 22M | 33M | 29M | 32M |
Other income expense | — | — | — | — |
Pretax income | 71M | 156M | 114M | 76M |
Tax provision | 4M | 37M | 6M | 13M |
Net income | 67M | 119M | 108M | 63M |
Basic EPS | 0.5 | 0.9 | 0.8 | 0.5 |
Diluted EPS | 0.5 | 0.9 | 0.8 | 0.5 |
Basic average shares | 125.0M | 126.2M | 126.2M | 126.2M |
Diluted average shares | 125.0M | 127.4M | 126.2M | 127.8M |
EBITDA | 154M | 252M | 203M | 172M |
Net income from continuing op. | 67M | 119M | 108M | 63M |
Minority interests | 0 | -3M | -2M | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |